A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
About this item
Full title
Author / Creator
Claassens, Daniel M F , Vos, Gerrit J A , Bergmeijer, Thomas O , Hermanides, Renicus S , van 't Hof, Arnoud W J , van der Harst, Pim , Barbato, Emanuele , Morisco, Carmine , Tjon Joe Gin, Richard M , Asselbergs, Folkert W , Mosterd, Arend , Herrman, Jean-Paul R , Dewilde, Willem J M , Janssen, Paul W A , Kelder, Johannes C , Postma, Maarten J , de Boer, Anthonius , Boersma, Cornelis , Deneer, Vera H M and Ten Berg, Jurriën M
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
It is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2Y
inhibitors.
We conducted a randomized, open-label, assessor-blinded trial in which patients undergoing primary PCI with stent implantation were assigned in a 1:1 ratio to receive either a P2Y
inhibit...
Alternative Titles
Full title
A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
Authors, Artists and Contributors
Author / Creator
Vos, Gerrit J A
Bergmeijer, Thomas O
Hermanides, Renicus S
van 't Hof, Arnoud W J
van der Harst, Pim
Barbato, Emanuele
Morisco, Carmine
Tjon Joe Gin, Richard M
Asselbergs, Folkert W
Mosterd, Arend
Herrman, Jean-Paul R
Dewilde, Willem J M
Janssen, Paul W A
Kelder, Johannes C
Postma, Maarten J
de Boer, Anthonius
Boersma, Cornelis
Deneer, Vera H M
Ten Berg, Jurriën M
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1056_NEJMoa1907096
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1056_NEJMoa1907096
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1907096
